EVALUATION OF AVAILABILITY OF DRUGS USED FOR DYSPEPTIC SYNDROME IN THE KYRGYZ REPUBLIC

Abstract

The article presents the results of the analysis of the physical and economic availability of drugs used for dyspepsia, which is one of the priority indicators characterizing the adequate functioning of the country's drug supply system. The key 8 drugs included in the 2018 edition of the List of Essential Medicines of the Kyrgyz Republic, the prices of drugs used for dyspepsia syndrome according to the price lists of retail pharmacy institutions and data of the National Statistical Committee of the Kyrgyz Republic on the wages of the population were taken as objects of study.As a result of the study, it was found that in the Bishkek, Talas, Jalal-Abad and Batken regions, the physical availability of 8monitored drugs was 100%. Analysis of drugs used for peptic ulcer in accordance with the guidelines approved by the Ministry of Health of the Kyrgyz Republic «Clinical Guidelines for the diagnosis and treatment of uncomplicated peptic ulcer in the active phase at the primary level of health care in the Kyrgyz Republic» showed that a 30-day course of therapy with proton pump inhibitors under the trade names Nolpaza, Omez, Stamik, Pantap and Ulsepan, which have high turnover ratios, cost significantly more than the minimum daily wage and are economical inaccessible. And only the use of Nolpase is affordable for patients in relation to the average daily wage.